NEW YORK, March 1 - Shares in Invitrogen fell sharply as the company warned that first-quarter revenue and earnings will be smaller than expected due to currency-exchange rates and weakness in some of its business units.
Already have a GenomeWeb or 360Dx account?Login Now.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.